CNS Stimulants: Psychedelic Agents
Hallucinogens and Psychedelics
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 26, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Joga Chaganti1, Krista J Siefried1, Veda S Vyakaranam1
1From the Thomas Jefferson University (J.C.); St. Vincent's Hospital Alcohol and Drug Service (K.J.S., L.A.), Sydney, Australia; National Drug and Alcohol Research Centre (NDARC) (K.J.S., L.A.), The University of New South Wales, Randwick, Australia; New South Wales Drug and Alcohol Clinical Research and Improvement Network (DACRIN) (K.J.S., L.A.), c/o the Ministry of Health, Sydney, Australia; Jefferson Integrated Magnetic Resonance Imaging Center (JIMRIC) (V.S.V.), Thomas Jefferson University, Philadelphia-19107, USA and St. Vincent's Clinical School (J.B), University of New South Wales, Sydney, Australia.
Psilocybin treatment, combined with psychotherapy, reorganized brain networks in individuals with methamphetamine use disorder. This intervention improved functional connectivity and was linked to reduced drug use and psychological distress.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: